SeQuent Scientific Limited (SeQuent), India's leading animal health company with a strong presence in veterinary formulations and APIs, has signed a definitive agreement on 07 November 2022 to acquire 100% stake in Tineta Pharma Private Limited (Tineta), a company incorporated in India.
Sequent Software has announced the launch of its newest platform, 3PSecure, in connection with its collaboration with Invicta Health Solutions, a...
Net profit of Solara Active Pharma Sciences rose 59.09% to Rs 65.80 crore in the quarter ended December 2020 as against Rs 41.36 crore during the previous quarter ended December 2019. Sales rose 24.15% to Rs 426.69 crore in the quarter ended December 2020 as against Rs 343.68 crore during the previous quarter ended December 2019. ParticularsQuarter EndedDec. 2020Dec. 2019% Var.Sales426.69343.68 24 OPM %24.6922.60 -PBDT93.1865.17 43 PBT65.7941.33 59 NP65.8041.36 59
SeQuent Scientific launches Citramox LA injection in 10 European countriES
NEW DELHI: Drug firm SeQuent Scientific Ltd NSE 1.86 % on Tuesday announced the launch of veterinary medicine Halofusol in 19 European countries.
Days after acquiring India’s largest pure-play animal healthcare company , Bengaluru based Sequent Scientific Ltd, The Carlyle Group is close to striking yet another pharma deal down south. This time the American private equity giant is teaming up with pharma veteran and ex-Mylan Labs senior executive B Hari Babu, said people familiar with the matter.
Amid the voluntary recall of Nizatidine API by Mylan, Solara Active Pharma Sciences on Thursday said its last supplies of the drug to the firm were made in September 2017 and it will conduct an internal investigation.
Private equity investors, including US-based Advent International and home-grown fund Kedaara Capital, are in initial talks to acquire SequentNSE -1.43 % Scientific Ltd, India's largest animal healthcare company. In this proposed deal, which is expected in the range of Rs 2,500 crore ($350 million), promoters and an existing private equity investor will exit, two people aware of the development said.
Sequent Scientific to acquire Solara Active Pharma Sciences' EU-GMP API facility at Mahad
It said most of the APIs for those drugs are expected to come from an API plant in Ambernath, Maharashtra, India that Strides Shasun agreed in December to buy from Perrigo. Perrigo agreed to sell the plant, valued at $42.6 million, for INR 1000 million ($14.8 million). Strides will continue to produce some of Perrigo’s products at the plant, which it will supply to Perrigo under a long-term agreement. The deal is expected to close by the end of March.